Neurology ReviewsNoninvasive Stimulation May Reduce Fatigue and Improve Memory in MSNovember 3, 2015Multiple Sclerosis
Neurology ReviewsAnti-TNFs May Double the Risk of Demyelinating DiseasesNovember 3, 2015Multiple Sclerosis
Clinical Neurology NewsOcrelizumab decreases relapses, brain lesion development in relapsing-remitting MSOctober 17, 2015Multiple Sclerosis
Clinical Neurology NewsOcrelizumab posts first-ever positive outcome data for primary progressive MSOctober 14, 2015Multiple Sclerosis
Clinical Neurology NewsDaclizumab’s efficacy against MS tempered by adverse eventsOctober 14, 2015Multiple Sclerosis
Neurology ReviewsSodium Channel Blockade With Phenytoin Has a Neuroprotective Effect After Acute Optic NeuritisOctober 13, 2015Multiple Sclerosis
Neurology ReviewsAnti-JCV Antibody Index and L-Selectin Hone PML Risk Stratification During Natalizumab TherapyOctober 13, 2015Multiple Sclerosis
Neurology ReviewsCannabinoid Spray Effectively Relieves MS-Related SpasticityOctober 13, 2015Multiple Sclerosis
Neurology ReviewsDaclizumab Reduces Brain Volume Loss, Compared With InterferonOctober 13, 2015Multiple Sclerosis
Neurology ReviewsLong-Term Efficacy of Fingolimod Reinforced by New NEDA-4 Analysis October 13, 2015Multiple Sclerosis
